Xpand Biotechnology

Bilthoven, Netherlands Founded: 2004 • Age: 22 yrs Acquired By Kuros Biosciences
Mini-bioreactors are developed as alternatives to 2D cell culture systems.

About Xpand Biotechnology

Xpand Biotechnology is a Healthcare company based in Bilthoven (Netherlands) founded in 2004, and was acquired by Kuros Biosciences in December 2016. Mini-bioreactors are developed as alternatives to 2D cell culture systems. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems.

Company details

Xpand Biotechnology was founded in 2004 in Bilthoven, Netherlands, within the biotechnology sector. Mini-bioreactors for cell culture are developed as substitutes for conventional 2D systems. These are utilized in regenerative medicine research, with emphasis placed on bone tissue regeneration through calcium phosphate-based materials exhibiting osteoconductive properties. Operations focus on advancing cell culture technologies for biomedical applications.

  • Headquarters Bilthoven, Netherlands
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website xpand-biotech.com
  • Acquired by Kuros Biosciences (Dec 2016)
Key Metrics

Funding Insights of Xpand Biotechnology

  • Total Rounds 7
  • Last Round Grant β€” $2.1M
  • First Round $310,800

    (Feb 2004)

  • Investors Count 2

All 7 funding rounds of Xpand Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2017$2.1MGrant––
Jan 2017$1.08MGrant––
Jul 2015$2.03MGrant––
Feb 2007$7.11MGrant––
–
Jul 2005$2.06MGrant––
–
Apr 2005$2.45MGrant––
–
Feb 2004$310,800Grant––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Xpand Biotechnology

Xpand Biotechnology has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Kuros Biosciences, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Provider of smart solutions for bone disease management
2000kurosbio.comSchlieren, Switzerland
Premium access

Investor details for Xpand Biotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Xpand Biotechnology

4 dated milestones of Xpand Biotechnology across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Xpand Biotechnology is founded.
  2. Funding First funding round of $311K.
  3. Exit Acquired by Kuros Biosciences.
  4. Funding Latest funding round, Grant, of $2.1M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Xpand Biotechnology

Xpand Biotechnology was founded in 2004.

Xpand Biotechnology is headquartered in Bilthoven, Netherlands. It is registered at Bilthoven, Utrecht, Netherlands.

Xpand Biotechnology was founded in 2004 in Bilthoven, Netherlands, within the biotechnology sector. Mini-bioreactors for cell culture are developed as substitutes for conventional 2D systems. These are utilized in regenerative medicine research, with emphasis placed on bone tissue regeneration through calcium phosphate-based materials exhibiting osteoconductive properties. Operations focus on advancing cell culture technologies for biomedical applications.

Xpand Biotechnology has 3 investors. Key investors include Kuros Biosciences, European Union, and EIC Fund.

Yes. Xpand Biotechnology was acquired by Kuros Biosciences in December 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available